Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 317 Squamous Cell Carcinoma of Head and Neck 168 Head and Neck Neoplasms 150 Carcinoma, Non-Small-Cell Lung 97 Colonic Neoplasms 90 Rectal Neoplasms 82 Neoplasm Metastasis 72 Neoplasms 60 Pancreatic Neoplasms 40 Carcinoma, Squamous Cell 40 Lung Neoplasms 35 Esophageal Neoplasms 25 Breast Neoplasms 22 Stomach Neoplasms 20 Recurrence 20 Carcinoma 18 Laryngeal Neoplasms 17 Tongue Neoplasms 16 Mouth Neoplasms 16 Oropharyngeal Neoplasms 14 Esophageal Squamous Cell Carcinoma 14 Salivary Gland Neoplasms 12 Adenocarcinoma Of Esophagus 12 Hypopharyngeal Neoplasms 11 Colorectal Cancer Metastatic 11 Laryngeal Diseases 10 Adenocarcinoma of Lung 10 Uterine Cervical Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Ovarian Neoplasms 9

Interventions

Metformin 2 Saline Solution 1 Lidocaine 1 Injections, Intradermal 1 Gels 1 Cyproterone Acetate 1 Cetuximab 1 Adrenal Cortex Hormones 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Acne Vulgaris × Cetuximab × Clear all

NCT01382407 2017-04-27

Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab

Rambam Health Care Campus

Acne Vulgaris

Data powered by HemOnc (CC BY 4.0) Colophon ⚡